A look at Seema Verma’s approach to reforming healthcare policy, and what it could mean for Medicare and Medicaid if she is confirmed as CMS administrator.
During her confirmation hearing before the Senate Finance Committee on Thursday, Seema Verma offered up some clues about how she might steer the agency, but remained vague on other issues.
Here are 5 takeaways from Verma’s confirmation hearing.
1. She has experience designing plans that align with conservative ideas
Prior to her nomination, Verma was the president, CEO, and founder of SVC, Inc, a health policy consulting company. Her most notable accomplishment was the Healthy Indiana Plan, a high-deductible, consumer-driven health plan that expanded Medicaid under the Affordable Care Act (ACA) for able-bodied adults in that state.
She touted the positive effects of the program in her testimony, but acknowledged that “every state is different” and it likely could not be implemented nationwide. However, the plan includes several components of Republicans’ potential framework for replacing the ACA, like expanding the use of health savings accounts.
2. Her testimony indicated opposition to vouchers, but an open mind on block grants and capitation
In the confirmation hearing, Verma said she would not support turning Medicare into a voucher plan. She did indicate that the door would be left open to other cost-cutting strategies.
“I think anything should be on the table that can improve health outcomes for this very vulnerable population,” she said in response to a question on block grants from Senator Dean Heller, R-Nevada. “I think block grants, per capita cap, anything that we can do to help improve outcomes and create a level of accountability for states, I think we should explore all of those options.”
3. “Patient choice” a common theme throughout hearing
Consistent with her work developing Indiana’s consumer-directed health plan, Verma strongly supported patients’ ability to make their own healthcare choices. In particular, she rejected the idea that low-income beneficiaries might have more difficulty making optimal decisions about their care.
“We can empower individuals to take ownership for their health, and that people, just because they don’t have income, doesn’t mean that they’re not capable and that they don’t want to have choices,” she said.
Later, when asked whether plans should be required to cover certain essential benefits, Verma said that she “support[s] Americans being able to decide what benefit package works best for them.”
4. She faced tough questions from Democrats
Democratic senators did not hold back during their questioning of Verma in the hearing. In one of the most pointed inquiries, Senator Debbie Stabenow, D-Michigan, asked if she believed women should have to pay more for insurance that covers prenatal care and maternity services, which the ACA required insurers to cover without charging higher premiums. Verma, careful to avoid the appearance of supporting the ACA, did not directly answer the question.
“I’m a woman, so I obviously support women having access to the care that they need,” she said. When Stabenow pressed her to answer whether women should be charged more for insurance because of their gender, Verma answered that “women should be able to make the decisions that work best for them.”
5. Psychiatric services could be a potential conflict of interest
Senator Bob Melendez, D-New Jersey, asked Verma whether she would ensure Medicaid would provide similar levels of coverage across states for children with autism, but she could not answer that question. The Office of Government Ethics had advised her not to participate in discussions about mental health services since her husband is a child psychiatrist, she explained.
It remains unclear how issues relating to psychiatric services would be handled if Verma is confirmed as CMS administrator, which appears likely.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More